TAG1 Announces Strategic Collaboration to Advance Targeted Alpha Therapies
PR Newswire —
ST. LOUIS, March 2, 2026 /PRNewswire/ -- TAG1 Inc. (TAG1) today announced a collaboration with the Molecular Cancer Imaging Facility (MCIF) at Dana-Farber Cancer Institute designed to accelerate the development of targeted alpha therapies and expand access to next generation radioisotopes...